/HTSUY
HTSUY Stock - Hisamitsu Pharmaceutical Co., Inc.
Healthcare|Medical - PharmaceuticalsOTC
$6.65+0.00%
+$0.00 (+0.00%) • Dec 19
66
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.46
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $7.32
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HTSUY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$6.58 – $6.72
TARGET (TP)$7.65
STOP LOSS$6.12
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.16
52W High$7.08
52W Low$6.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.02B | $141.71B | $128.33B | $1.08B | $1.08B |
| Gross Profit | $597.94M | $78.97B | $541.83M | $628.40M | $652.82M |
| Gross Margin | 58.5% | 55.7% | 0.4% | 58.3% | 60.4% |
| Operating Income | $123.89M | $13.17B | $11.60B | $83.74M | $100.72M |
| Net Income | $142.66M | $13.97B | $87.52M | $9.66B | $87.31M |
| Net Margin | 13.9% | 9.9% | 0.1% | 895.9% | 8.1% |
| EPS | $0.48 | $0.32 | $0.28 | $0.27 | $0.27 |
Company Overview
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HTSUYBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.11
Q4 2025
EPS Surprise History
Q3 23
No data
Q4 23
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 8, 2026 | — | — | — | — |
Q1 2026 | Jan 7, 2026 | — | — | — | — |
Q4 2025 | Oct 8, 2025 | — | $0.11 | — | — |
Q3 2025 | Jul 10, 2025 | — | $0.06 | — | — |
Q2 2025 | Apr 10, 2025 | — | $0.18 | — | — |
Q1 2025 | Jan 9, 2025 | — | — | — | — |
Q4 2024 | Oct 10, 2024 | — | $0.10 | — | — |
Q3 2024 | Jul 11, 2024 | — | $0.04 | — | — |
Q2 2024 | May 30, 2024 | — | $0.10 | — | — |
Q4 2023 | Nov 29, 2023 | — | $0.08 | — | — |
Q3 2023 | Aug 30, 2023 | — | $0.10 | — | — |
Q2 2023 | May 30, 2023 | — | $0.10 | — | — |
Q1 2023 | Feb 27, 2023 | — | $0.05 | — | — |
Q4 2022 | Nov 29, 2022 | — | $0.07 | — | — |
Q3 2022 | Aug 30, 2022 | — | $0.11 | — | — |
Q2 2022 | May 30, 2022 | — | $0.04 | — | — |
Q1 2022 | Feb 27, 2022 | — | $0.09 | — | — |
Q4 2021 | Nov 29, 2021 | — | $0.03 | — | — |
Q3 2021 | Aug 30, 2021 | — | $0.07 | — | — |
Q2 2021 | May 30, 2021 | — | $0.07 | — | — |
Latest News
Loading news...
Frequently Asked Questions about HTSUY
What is HTSUY's current stock price?
Hisamitsu Pharmaceutical Co., Inc. (HTSUY) is currently trading at $6.65 per share. The stock has moved +0.00% today.
What is the analyst price target for HTSUY?
No analyst price targets are currently available for this stock.
What sector is Hisamitsu Pharmaceutical Co., Inc. in?
Hisamitsu Pharmaceutical Co., Inc. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.
What is HTSUY's market cap?
Hisamitsu Pharmaceutical Co., Inc. has a market capitalization of $1.89 billion, making it a small-cap company.
Does HTSUY pay dividends?
No, Hisamitsu Pharmaceutical Co., Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorEBOSY
EBOS Group Limited
$35.03
Mkt Cap: $1.7B
EKTAF
Elekta AB (publ)
$5.95
Mkt Cap: $2.2B
EKTAY
Elekta AB (publ)
$6.04
Mkt Cap: $2.4B
HTSUF
Hisamitsu Pharmaceutical Co., Inc.
$29.00
Mkt Cap: $2.1B
OSSFF
Embla Medical hf.
$5.33
Mkt Cap: $2.3B
RTEZ
Rest Ez Inc.
$70.00
Mkt Cap: $1.9B
SAEYY
Redcare Pharmacy N.V.
$7.50
Mkt Cap: $1.5B
SHPPF
Redcare Pharmacy N.V.
$75.00
Mkt Cap: $1.5B
STSEY
Stratec SE
$5.10
Mkt Cap: $1.5B
VTRLY
Vitrolife AB (publ)
$15.06
Mkt Cap: $2.0B
Explore stocks similar to HTSUY for comparison